Results 211 to 220 of about 83,951 (257)

Navigating the Data Gaps of Ageing Among Women Living With HIV

open access: yes
Journal of the International AIDS Society, Volume 29, Issue 3, March 2026.
Caroline A. Sabin   +3 more
wiley   +1 more source

Drug-Resistant Tuberculosis

Disease-a-Month, 2006
Eastern Europe, Henan province in China, and certain parts of Russia. 1 The resistance to single drug was reported to range from 2 to 41% (median 9.9%) and to multiple drugs was 0 to 14.4% (prevalence 1.4%) in those who never received prior treatment.
Joel Anthony, Nations   +2 more
openaire   +2 more sources

Extensively Drug-resistant Tuberculosis

The American Journal of Medicine, 2008
Extensively drug-resistant tuberculosis (XDR-TB) is defined as Mycobacterium tuberculosis infection that is resistant to isoniazid, rifampin, any fluoroquinolone, and any injectable drug (amynoglicosides or polypetides). Although initially described in South Africa, it has emerged as a global threat, and cases have been reported from several countries,
Miguel G, Madariaga   +2 more
openaire   +4 more sources

DRUG RESISTANCE IN TUBERCULOSIS

Infectious Disease Clinics of North America, 1997
Drug-resistant tuberculosis remains a worldwide problem. New laboratory methods have improved our ability to more rapidly identify resistant strains, but the most effective approach is to prevent the appearance of resistance by appropriate choice of antibiotics and directly-observed therapy.
L M, Parsons   +3 more
openaire   +2 more sources

Drug-resistant tuberculosis

The Lancet, 2001
Abstract: This paper summarizes the presentations of the meeting on drug‐resistant tuberculosis held in London in March of 2001. Multidrug‐resistant tuberculosis (MDR TB) is defined and the causes, risk factors, and recent treatment advances are briefly described. The larger social and economic environment in which MDR TB occurs is discussed.
openaire   +3 more sources

MULTIPLE DRUG–RESISTANT TUBERCULOSIS

Infectious Disease Clinics of North America, 1998
The national and international emergence of drug-resistant M. tuberculosis has complicated both the programmatic control of the tuberculosis epidemic and the clinical management of individual cases. In the United States, the problem of MDR tuberculosis is regionalized and likely stems from multifactorial causes, including the concurrent HIV epidemic ...
W Z, Bradford, C L, Daley
openaire   +2 more sources

Drug-resistant tuberculosis

Current Opinion in Pulmonary Medicine, 2000
There is increasing concern in many countries about the problem of drug-resistant tuberculosis, particularly so because no new classes of drugs have been developed for the treatment of tuberculosis since the 1960s. Although drug resistance is thought to be fairly common in some countries and rare in others, the global extent of this condition is not ...
openaire   +2 more sources

Multi-Drug Resistant and Extensively-Drug Resistant Tuberculosis

The Indian Journal of Pediatrics, 2020
India is one of the high burden countries for tuberculosis (TB) including multi-drug resistant TB (MDR-TB) and extensively-drug resistant (XDR) TB. Drug-resistant (DR) TB has threatened the TB care and is a major health problem in many countries; treatment of DR TB has been difficult requiring use of reserve or second-line drugs, cost factors, has ...
Ira, Shah   +2 more
openaire   +2 more sources

Drug-resistant Tuberculosis

Pediatric Infectious Disease Journal, 2011
Drug-resistant Mycobacterium tuberculosis (TB) infection represents a serious and growing problem. For patients infected or suspected of being infected with multidrug or extensively drug-resistant TB, several medications have to be given simultaneously for prolonged periods.
Mona, Al-Dabbagh   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy